Pain News and Research

Latest Pain News and Research

arGEN-X generates potent antibody antagonists of Nav1.7 using SIMPLE Antibody technology

arGEN-X, a clinical stage human monoclonal antibody therapeutics company, announces it has successfully generated potent antibody antagonists of Nav1.7, using its proprietary SIMPLE Antibody™ technology.

12 Sep 2013

Electroacupuncture treatment improves visceral hypersensitivity in irritable bowel syndrome

Irritable bowel syndrome patients extensively suffer from chronic visceral hypersensitivity, with involvement of all levels of the brain-gut axis, as well as various neurotransmitters.

12 Sep 2013

Study finds low doses of vancomycin to be effective in treating serious C-difficile infection

Clostridium difficile infection (CDI) treatment in a hospital setting using low dose oral vancomycin showed similar effectiveness compared to high dose, according to a new study by researchers at Montefiore Medical Center and Albert Einstein College of Medicine of Yeshiva University.

12 Sep 2013

FDA takes steps to restrict the use of pain meds

The Food and Drug Administration will require a class-wide label change for long-acting opioids aimed at limiting use of these drugs to patients with severe, refractory pain.

12 Sep 2013

Research shows smoking and obesity together may pose triple health threat

Millions of people who are obese and smoke tobacco may face additional health problems — including their responses to common prescription medicines — that extend beyond the well-known links with cancer, heart attacks and stroke, according to a report presented here today.

12 Sep 2013

Hydroxyurea treatment prevents complications, lowers medical care costs in children sickle cell disease

The benefits of hydroxyurea treatment in people with sickle cell disease are well known -- fewer painful episodes, fewer blood transfusions and fewer hospitalizations. Now new research from the Johns Hopkins Children's Center and other institutions reveals that by preventing such complications, the drug can also considerably lower the overall cost of medical care in children with this condition.

12 Sep 2013

Patients with longer-lasting chest pain more likely to have heart attack

Patients with longer-lasting chest pain are more likely having a heart attack than those with pain of a shorter duration, according to a study by researchers at Henry Ford Hospital.

12 Sep 2013

First Edition: September 11, 2013

Today's headlines include reports that some House GOP lawmakers are taking a hard line against funding for the health law in the ongoing debate about raising the nation's debt limit.

11 Sep 2013

Szechuan pepper found to mimic sense of touch in brain

The science behind the tingling sensation caused by eating a popular Asian spice has been explained by researchers at UCL.

11 Sep 2013

Pain, itching associated with shingles may be due to virus causing "short circuit" in nerve cells

The pain and itching associated with shingles and herpes may be due to the virus causing a "short circuit" in the nerve cells that reach the skin, Princeton researchers have found.

11 Sep 2013

Parent's guide book for caring children living with juvenile arthritis

Parents who have children with chronic autoimmune diseases like juvenile arthritis face a lifetime of obstacles and challenges and now there's a book to help them. In Living with Juvenile Arthritis: A Parent's Guide, author Kimberly Poston Miller shares with readers her hard-earned wisdom and experiences as the mother of two children living with juvenile arthritis and a number of related autoimmune conditions.

11 Sep 2013

New bill allows Californians to directly access physical therapist services

California's Senate passed AB 1000 (Wieckowski/Maienschein) to allow Californians to directly access physical therapist services. The bill passed off the Senate Floor and now goes back to the Assembly to approve amendments before heading to the Governor's desk.

11 Sep 2013

Large numbers of kidney disease patients inappropriately prescribed statins to lower cholesterol

A new analysis concludes that large numbers of patients in advanced stages of kidney disease are inappropriately being prescribed statins to lower their cholesterol - drugs that offer them no benefit and may increase other health risks such as diabetes, dementia or muscle pain.

11 Sep 2013

Safety labeling changes announced for extended-release and long-acting opioid analgesics

The U.S. Food and Drug Administration today announced class-wide safety labeling changes and new postmarket study requirements for all extended-release and long-acting opioid analgesics intended to treat pain.

11 Sep 2013

Not-So-Total Recall: Selectively Erasing Unwanted Memories

...

10 Sep 2013

Omeros seeks EMA's approval to market OMS302 for patients undergoing ILR surgery

Omeros Corporation today announced that it recently submitted a Marketing Authorization Application to the European Medicines Agency seeking approval to market OMS302 for use in patients undergoing intraocular lens replacement surgery in the European Union.

10 Sep 2013

Relmada Therapeutics reports positive results from pivotal pharmacokinetic study of LevoCap ER

Relmada Therapeutics Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced a positive outcome of its pivotal pharmacokinetic study for LevoCap ER. Based on the positive outcome of this study, Relmada is now preparing the Phase III development program and is planning to submit a request with the FDA to discuss the final pathway to the New Drug Application for this product during the fourth quarter of this year.

10 Sep 2013

Hospira announces EC approval of Inflectra, Europe's first biosimilar mAb therapy

Hospira, the world's leading provider of injectable drugs and infusion technologies, today announced the European Commission (EC) approval of Inflectra™ (infliximab), Europe's first biosimilar monoclonal antibody (mAb) therapy. Inflectra has been approved for the treatment of inflammatory conditions including rheumatoid arthritis (RA), ankylosing spondylitis, Crohn's disease (CD), ulcerative colitis (UC), psoriatic arthritis (PsA) and psoriasis.

10 Sep 2013

DO-HEALTH study aims to provide evidence for strategies that prevent chronic disease in seniors

Europe's largest healthy ageing study - DO-HEALTH - which aims to provide evidence for the safety of three simple preventive interventions: vitamin D, omega-3 fatty acids and a simple home exercise programme, has recruited 532 of its target 2,000 seniors.

10 Sep 2013

Most patients who report statin intolerance can actually tolerate drugs on subsequent trials

Most patients who report statin intolerance, including muscle aches and other side effects from the cholesterol-lowering drugs, can actually tolerate drugs from this class on subsequent trials, according to research from Cleveland Clinic recently released online and forthcoming in the September issue of the American Heart Journal. The study is the largest ever to examine the effects of re-challenging statin-intolerant patients.

10 Sep 2013

Pain News and Research

Latest Pain News and Research

arGEN-X generates potent antibody antagonists of Nav1.7 using SIMPLE Antibody technology

Electroacupuncture treatment improves visceral hypersensitivity in irritable bowel syndrome

Study finds low doses of vancomycin to be effective in treating serious C-difficile infection

FDA takes steps to restrict the use of pain meds

Research shows smoking and obesity together may pose triple health threat

Hydroxyurea treatment prevents complications, lowers medical care costs in children sickle cell disease

Patients with longer-lasting chest pain more likely to have heart attack

First Edition: September 11, 2013

Szechuan pepper found to mimic sense of touch in brain

Pain, itching associated with shingles may be due to virus causing "short circuit" in nerve cells

Parent's guide book for caring children living with juvenile arthritis

New bill allows Californians to directly access physical therapist services

Large numbers of kidney disease patients inappropriately prescribed statins to lower cholesterol

Safety labeling changes announced for extended-release and long-acting opioid analgesics

Not-So-Total Recall: Selectively Erasing Unwanted Memories

Omeros seeks EMA's approval to market OMS302 for patients undergoing ILR surgery

Relmada Therapeutics reports positive results from pivotal pharmacokinetic study of LevoCap ER

Hospira announces EC approval of Inflectra, Europe's first biosimilar mAb therapy

DO-HEALTH study aims to provide evidence for strategies that prevent chronic disease in seniors

Most patients who report statin intolerance can actually tolerate drugs on subsequent trials

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Pain News and Research

Latest Pain News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in